OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A novel therapeutic approach to modulate the inflammatory cascade: A timely exogenous local inflammatory response attenuates the sepsis-induced cytokine storm
Meng Gong, Shiyi Qi, Zhiting Wu, et al.
Cytokine (2024) Vol. 176, pp. 156533-156533
Closed Access | Times Cited: 3
Meng Gong, Shiyi Qi, Zhiting Wu, et al.
Cytokine (2024) Vol. 176, pp. 156533-156533
Closed Access | Times Cited: 3
Showing 3 citing articles:
Knockout or treatment with an antagonist of formyl peptide receptor 1 protects mice from sepsis by inhibiting inflammation
Gang Ma, Jie Ma, Baofu Qu, et al.
Cytokine (2025) Vol. 187, pp. 156872-156872
Closed Access
Gang Ma, Jie Ma, Baofu Qu, et al.
Cytokine (2025) Vol. 187, pp. 156872-156872
Closed Access
Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management—A Narrative Review
Arabela-Codruta Cocea, Cristian Ioan Stoica
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 537-537
Open Access | Times Cited: 2
Arabela-Codruta Cocea, Cristian Ioan Stoica
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 537-537
Open Access | Times Cited: 2
Arginine Modified Pvdf Affinity Membrane with Favorable Hemocompatibility for Highly Efficient Removal of Interleukin-6 from Blood
Juanjuan Liu, Shuyun Zheng, Qingqing Wang, et al.
(2024)
Closed Access
Juanjuan Liu, Shuyun Zheng, Qingqing Wang, et al.
(2024)
Closed Access
